StockData
Lantern Pharma Inc. logo

Lantern Pharma Inc. (LTRN) stock

LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 5/30
$0.33−0.04 (-9.78%)

Close on Nov 18, 2026Market cap $4.21MP/E –Yield –

Lantern Pharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lantern Pharma's price to book ratio was 8.6× on Jul 31, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.6× to 13.6×, with a median of 1.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 20268.6×+5.1
2025Dec 31, 20253.5×+2.2
2024Dec 31, 20241.3×+0.3
2023Dec 29, 20231.0×−0.1
2022Dec 30, 20221.1×−0.1
2021Dec 31, 20211.2×−4.4
2020Dec 31, 20205.5×–

More Lantern Pharma figures

See a number that looks wrong?